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Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA)
reductase, which inhibits the synthesis of endogenouse cholesterol. Numerous studies
demonstrate that statins increase the risk of new-onset diabetes in long-term therapy,
but underlying the pathological effects is still unclear. In our study, mouse muscle cell
C2C12 cells were differentiated and treated with simvastatins in presence or absence
of the mevalonolactone, and then western-blotting, flow cytometry, cytotoxicity assay
and glucose kit method were performed. These studies showed that simvastatin could
significantly reduced glucose uptake, whereas its effects were reversed by mevalonate.
Mechanistic studies demonstrated that simvastatins inhibited the phosphorylation of
IR, IRS-1 and Akt, and the translocation of GLUT4. Collectively, our findings
indicate that simvastatins inhibit IR-dependent IRS-1/PI3K/Akt pathway, leading to
suppress glucose uptake. These results provide an important new insight into the
mechanism of statins on insulin sensitivity which may be associated with new-onset
diabetes.






































































2.8.2 流式细胞术检测骨骼肌细胞中 GLUT4转位到质膜的数目... 22














3.4 辛伐他汀损害 IR介导的 IRS-1/PI3K/Akt 信号通路.............................. 33
第四章 讨论与展望................................................................................. 36
英文缩略词表........................................................................................... 44















Abstract in Chinese.................................................................................... I
Abstract in English................................................................................... II
Chapter 1 Introductio................................................................................1
Chapter 2 Material and method...............................................................7
2.1 Main reagent....................................................................................................7
2.2 Main instruments and consumables..............................................................9
2.3 Main reagent preparation method...............................................................11
2.4 Cell Culture................................................................................................... 14
2.4.1 The recovery of mouse muscle cell line C2C12............................14
2.4.2 The culture and subculture of C2C12............................................14
2.4.3 The cryopreservation of C2C12.................................................... 15
2.4.4 The differentiation of C2C12........................................................ 15
2.5 Determine the time course for simvastatin-stimulated glucose uptake( the
Glucose Kit method ).............................................................................................. 16
2.5.1 The sample preparation................................................................. 16
2.5.2 Preparation of the reagent..............................................................16
2.5.3 The glucose kit method reaction conditions..................................17
2.5.4 Preparation of reaction system...................................................... 17
2.6 Effect of simvastatin on skeletal muscle cells............................................. 17
2.6.1 The sample preparation................................................................. 17
2.6.2 The glucose kit method with different concentrations of
simvastatin on skeletal muscle cells...............................................................18
2.6.3 Cell counting kit-8 assay with different concentrations of
simvastatin on the impact of the number of skeletal muscle cells (cytotoxicity
assay).............................................................................................................. 18
2.7 Effect of simvastatin on insulin action........................................................ 19














2.7.2 The glucose kit method with different concentrations of
simvastatin on insulin action.......................................................................... 20
2.7.3 Statistical analysis...................................................................... 20
2.8 Effect of simvastatin on GLUT4 translocation.......................................... 21
2.8.1 The sample preparation................................................................. 21
2.8.2 Flow cytometrywith different concentrations of simvastatin on
GLUT4 translocation......................................................................................22
2.9 Effect of simvastatin on IR-dependent IRS-1/PI3K/Akt pathway........... 22
2.9.1 The sample preparation................................................................. 22
2.9.2 Extraction of total cellular protein.................................................23
2.9.3 BCA assay with concentrations of total protein............................ 24
2.9.4 Protein denaturation.......................................................................25
2.9.5 Preparation of the western blot......................................................25
2.9.6Loading and electrophoresis...........................................................26
2.9.7 transfer to polyvinylidene difluoride membrane........................ 26
2.9.8 Immune response...........................................................................27
2.9.9Developing and fixing.................................................................... 27
Chapter 3 Result...................................................................................... 29
3.1 Effect of simvastatin on skeletal muscle cells............................................. 29
3.2Simvastatin prevented insulin action in skeletal muscle cells....................31
3.3Simvastatin decreased the translocation of GLUT4 in skeletal muscle
cells........................................................................................................................... 31
3.4 Simvastatin inhibited IR-dependent IRS-1/PI3K/Akt pathway............... 33





















并抑制其生物学作用，从而阻断 HMG-CoA 的转化。HMG-CoA 转化的减少可
使内源性胆固醇的合成减少。而细胞内游离胆固醇的减少会在转录水平减弱其对
低密度脂蛋白(Low Density Lipoprotei，LDL）受体合成的抑制作用，从而间接刺
激 LDL 受体并导致受体密度的上调。LDL 受体密度的上调一方面可增加骨骼
肌细胞对 LDL的吸收，引起血清 LDL的减少；另一方面，上调的 LDL 受体密
度可增加其与低密度脂蛋白胆固醇（Low Density Lipoprotein- cholesterol，LDL-C）

































Naveed Sattar 等学者发表的 meta分析发现，在入选的 13项随机安慰剂或标
准治疗对照研究中， 91140位参与者中有 4278位在 4年内发展为糖尿病，其中
他汀类药物治疗组的患者新发糖尿病的发病率较随机安慰剂组的患者增加 9%
(比值比 OR为 1.09; 95% 可信区间为 1.02–1.17)[5]。
Waters等发表的强化降低胆固醇预防卒中研究结果表明，经过 4.9年的随访，
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